NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
Status:
Completed
Trial end date:
2006-09-05
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this study is to investigate the safety and
efficacy of NovoLet® human insulin delivery system in an outpatient setting.